Analysis reveals improved efficiency in drug discovery through molecule generation, suggesting promise.
Traditional drug discovery suffers from high costs and low productivity, with compounds frequently failing due to insufficient efficacy or off-target binding. Structure-based approaches aim to address these challenges by directly...
No takes yet. Share an insight, caveat, or question.
Vost et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: